Status:
UNKNOWN
Treatment of Patients With Diabetic Kidney Disease
Lead Sponsor:
Assiut University
Conditions:
Diabetic Kidney Disease
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Due to irrespective of the limitations associated with estimated glomerular filtration rate (eGFR), it is crucial to develop new treatments that can effectively address these concerns. So, this study ...
Detailed Description
Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD) worldwide and continues to be the major contributor to kidney replacement therapy (KRT). Despite the significant d...
Eligibility Criteria
Inclusion
- Patients that suffer from Diabetic kidney disease (DKD)
Exclusion
- Genital mycotic infections
- Urosepsis and Pyelonephritis
- Lower limb amputation
- diabetic Ketoacidosis
- Euglycemic DKA
- Acute Kidney Injury
- Hypoglycemia
- Fournier Gangrene
- Hypersensitivity Reactions
- Bone fracture
- Bladder cancer
- Hyperkalemia
- Dyslipidemia
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06187493
Start Date
January 1 2024
End Date
December 31 2025
Last Update
January 2 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.